Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Feb 18:11:243.
doi: 10.3389/fimmu.2020.00243. eCollection 2020.

Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies

Guido Moll  1 , Martin J Hoogduijn  2 , James A Ankrum  3
Affiliations
Editorial

Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies

Guido Moll et al. Front Immunol. .
No abstract available

Keywords: efficacy; immunomodulation; mechanism of action; mesenchymal stem cells; mesenchymal stromal cells; potency analysis; regeneration; safety.

PubMed Disclaimer

Comment on

  • Editorial on the Research Topic Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies

References

    1. Moll G, Ankrum JA, Kamhieh-Milz J, Bieback K, Ringden O, Volk HD, et al. . Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines. Trends Mol Med. (2019) 25:149–63. 10.1016/j.molmed.2018.12.006 - DOI - PubMed
    1. Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. npj Regen Med. (2019) 4:22. 10.1038/s41536-019-0083-6 - DOI - PMC - PubMed
    1. Griffin MD, Elliman SJ, Cahill E, English K, Ceredig R, Ritter T. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots? Stem Cells. (2013) 31:2033–41. 10.1002/stem.1452 - DOI - PubMed
    1. Lalu MM, Mcintyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. . Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS ONE. (2012) 7:e47559. 10.1371/journal.pone.0047559 - DOI - PMC - PubMed
    1. Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. (2014) 32:252–60. 10.1038/nbt.2816 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources